Drug recall
Red Blood Cells, Leukocytes Reduced
FDA recall event 94412 · Class III · ImpactLife
Key facts
| Event ID | 94412 |
|---|---|
| Recall numbers | B-0287-2024, B-0288-2024 |
| Recalling firm | ImpactLife |
| Product type | Biologics |
| Products | Red Blood Cells, Leukocytes Reduced, Red Blood Cells, Leukocytes Reduced, Irradiated |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Blood Products, returned with transit time that was unacceptable and for which inspection was not performed or documented were distributed. |
| Initiation date | Jan 16, 2024 |
| Report date | May 15, 2024 |
| Termination date | May 9, 2024 |
| City | Ottumwa |
| State | IA |
| Country | United States |
| FEI number | 1970361 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: